ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
148 hedge funds and large institutions have $1.01B invested in Array Biopharma Inc in 2015 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 40 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
11% more funds holding
Funds holding: 133 → 148 (+15)
4% less capital invested
Capital invested by funds: $1.05B → $1.01B (-$41.2M)
Holders
148
Holding in Top 10
4
Calls
$23.7M
Puts
$13.4M
Top Buyers
| 1 | +$10.7M | |
| 2 | +$5.97M | |
| 3 | +$5.63M | |
| 4 |
GC
Guggenheim Capital
Chicago,
Illinois
|
+$3.59M |
| 5 |
RG
Redmile Group
San Francisco,
California
|
+$3.59M |
Top Sellers
| 1 | -$16.6M | |
| 2 | -$11.4M | |
| 3 | -$10.7M | |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
-$8.88M |
| 5 |
Millennium Management
New York
|
-$6.81M |